Secondary acute myeloid leukemia and early infection are independent predictors of poor survival in acute myeloid leukemia treated with hypomethylating agents and venetoclax
Hematological Oncology · 2024
DOI: 10.1002/hon.3310 ↗Kurz gefasst
Leserbrief in der Zeitschrift Hematological Oncology, 2024. Verfasst von Stefano Cordella und 11 weiteren Autor:innen. Beteiligte Einrichtung: Section of Hematology, Department of Medical and Surgical Sciences, Azienda Ospedaliero-Universitaria di Modena, University of Modena and Reggio Emil…. Hauptthemen laut MEDLINE: Bridged Bicyclo Compounds, Heterocyclic, Leukemia, Myeloid, Acute, Sulfonamides. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Section of Hematology, Department of Medical and Surgical Sciences, Azienda Ospedaliero-Universitaria di Modena, University of Modena and Reggio Emilia, Modena, Italy.
- Division of Hematology, ASUGI, Trieste, Italy.
- Division of Hematology, Ospedale Vito Fazzi, Lecce, Italy.
- Division of Hematology and Stem Cell Transplantation, ASUFC, University of Udine, Udine, Italy.
- Section of Hematology, Spedali Civili, Brescia, Italy.
- U.O. Oncoematologia, Fondazione IRCCS Ca' Granda OspedaleMaggiore Policlinico, University of Milan, Milan, Italy.
ORCID-Profile: Davide Lazzarotto, Chiara Cattaneo, Nicola Stefano Fracchiolla, Fabio Forghieri
Zitieren
APA
Cordella, S., Giusti, D., De Bellis, E., Dargenio, M., Creti', F., Lazzarotto, D., Cattaneo, C., Fracchiolla, N. S., Piccini, M., Forghieri, F., Pagano, L., & Candoni, A. (2024). Secondary acute myeloid leukemia and early infection are independent predictors of poor survival in acute myeloid leukemia treated with hypomethylating agents and venetoclax. Hematological Oncology. https://doi.org/10.1002/hon.3310
Vancouver
Cordella S, Giusti D, De Bellis E, Dargenio M, Creti' F, Lazzarotto D, et al. Secondary acute myeloid leukemia and early infection are independent predictors of poor survival in acute myeloid leukemia treated with hypomethylating agents and venetoclax. Hematological Oncology. 2024. doi:10.1002/hon.3310
BibTeX
@article{Cordella2024,
author = {Cordella, Stefano and Giusti, Davide and De Bellis, Eleonora and Dargenio, Michelina and Creti', Federica and Lazzarotto, Davide and Cattaneo, Chiara and Fracchiolla, Nicola Stefano and Piccini, Matteo and Forghieri, Fabio and Pagano, Livio and Candoni, Anna},
title = {Secondary acute myeloid leukemia and early infection are independent predictors of poor survival in acute myeloid leukemia treated with hypomethylating agents and venetoclax},
journal = {Hematological Oncology},
year = {2024},
doi = {10.1002/hon.3310}
}
EUVIMED